Government Affairs

We partner with our clients and broader healthcare system stakeholders to develop and implement policy strategies for healthcare transformation.

Incredible level of strategic GA insights with always a strong link to the business.

– Global Top 10 Pharma, International Director Government Affairs

About Government Affairs

  • Governments and regulators play a crucial role in influencing the economic value of biopharmaceutical companies. In particular, policymakers significantly impact access to innovative healthcare through measures such as austerity policies.
  • Many policymakers and influencers do not yet view biopharmaceutical companies as partners in shaping the future of healthcare. This perception is often influenced by traditional lobbying approaches and a lack of co-creation based on trust.
  • Government Affairs can demonstrate how strategic communication and stakeholder engagement support business objectives and how achieving favorable government policies and payer environments contributes to sustainable business growth.
  • At Executive Insight, we assist our clients across a wide range of policy topics, including value-based healthcare strategies, health equity initiatives, digital health and data, cost-containment measures, and healthcare sustainability.
     

Our Government Affairs Services:

  • Advocacy/policy frameworks & toolkits
  • Policy positions, narratives, briefs, white papers
  • Policy shaping vehicles & tools (e.g., joint publication, roundtable)
  • Payer & policymaker engagement activities (e.g., panels, advisory boards)
  • Multi-stakeholder workshops
Support external engagement / positioning

> Global healthcare trends analysis & implications

> Policy country benchmarking (incl. stakeholder analysis) & policy access barriers identification

> Corporate & function's GA strategy definition & strategy planning templates

> Global, regional & local policy strategy development & policy launch roadmap for a product

> Stakeholder engagement toolkit (e.g. trade association) & impact measurement & tracking tools (incl. metrics definition)

Advance strategy development
  • Organizational blueprinting based on environmental clustering & benchmark analysis
  • Capability building & training (incl. principles, processes, tools)
Facilitate organizational development / capability building

Contact our experts

Klarissa Hoday

Klarissa Hoday

Principal

mail_icon linkedin_icon
Arman Nilforoushan

Arman Nilforoushan

Director

mail_icon linkedin_icon

Related project cases and publications

How the ‘five Ps’ can close health equity gaps
Publication

How the ‘five Ps’ can close health equity gaps

Understanding and addressing healthcare inequity in the United States
Publication

Understanding and addressing healthcare inequity in the United States

Exploring the case for alternative access models
Publication

Exploring the case for alternative access models

Advances in gene therapy and the impact of CAR-T cell therapy for cancer patients
Publication

Advances in gene therapy and the impact of CAR-T cell therapy for cancer patients

EU’s new Joint Clinical Assessment (JCA): will patients have a say?
Publication

EU’s new Joint Clinical Assessment (JCA): will patients have a say?

Value-Based Healthcare (VBHC) in action: Key takeaways from ICHOM 2023
Publication

Value-Based Healthcare (VBHC) in action: Key takeaways from ICHOM 2023

Early Asset Strategy

 

Early Asset Strategy

Value Pull-through

 

Value Pull-through

Environment Transformation

 

Environment Transforma­tion

We use cookies to ensure we give you the best experience on our website. Detailed information on the use of cookies, and how you can disable them, is provided in our Privacy Policy. By using this site or clicking on "OK", you consent to the use of cookies.

OK